375
Participants
Start Date
June 4, 2024
Primary Completion Date
February 12, 2026
Study Completion Date
February 12, 2026
AZD5462
Participants will receive low, medium \& high doses of film-coated tablets of AZD5462 OD orally.
Placebo
Participants will receive matching doses of film-coated tablets of Placebo OD orally.
Research Site, Sofia
Research Site, Sofia
Research Site, Sofia
Research Site, Kistarcsa
Research Site, Nyíregyháza
Research Site, Pleven
Research Site, Herning
Research Site, Székesfehérvár
Research Site, Balatonfüred
Research Site, Aalborg
Research Site, Rosedale
Research Site, Buffalo
Research Site, Manassas
Research Site, Chapel Hill
Research Site, Miami
Research Site, Miami Beach
Research Site, Alexander City
Research Site, Knoxville
Research Site, Richmond
Research Site, Jaroměř
Research Site, Torrance
Research Site, Northridge
Research Site, Vista
Research Site, Vadodara
Research Site, Surat
Research Site, Kochi
Research Site, Kolkata
Research Site, Boston
Research Site, Brno
Research Site, Liberec
Research Site, Louny
Research Site, Pilsen
Research Site, Fukui-shi
Research Site, Higashiibaraki-gun
Research Site, Higashiohmi-shi
Research Site, Kitakyushu
Research Site, Kobe
Research Site, Kumamoto
Research Site, Miyazaki
Research Site, Morioka
Research Site, Naha
Research Site, Ōmihachiman
Research Site, Shūnan
Research Site, Breda
Research Site, Deventer
Research Site, Enschede
Research Site, Krakow
Research Site, Krakow
Research Site, Lodz
Research Site, Warsaw
Research Site, Wroclaw
Research Site, Wroclaw
Research Site, Bratislava
Research Site, Bratislava
Research Site, Košice
Lead Sponsor
AstraZeneca
INDUSTRY